Effectiveness of the ‘LeVe CPAP’ against the standard AIRVO CPAP among Covid-19 patients with Acute Hypoxemic Respiratory Failure at Mengo Hospital Kampala Uganda: A Cross-Over Randomised Trial.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR202109525822452

Enrollment

Registered

2021-09-28

Start date

2021-11-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Respiratory

Interventions

Crossover Trial

CrossOver Trial

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Positive for SARS COV 2 Age > 18 years SPO2 at 70

Exclusion criteria

Exclusion criteria: Failure to obtain consent /Refusal to participate Semi/unconscious/ critically ill Mental confusion Patient with severe oral ulceration Contraindication to CPAP such as Chronic Obstructive Airway Disease (COPD)

Design outcomes

Primary

Measure	Time frame
Mean difference of Oxygen saturation measured as SP02 from baseline to 6 hours with a non-inferiority margin of 1 to 2%	—

Secondary

Measure	Time frame
• Relative effects on heart rate • Blood pressure • Dyspnea/ respiratory rate, • Comfort, and tolerance measured as frequency of breaks from the device.	—

Countries

Uganda

Contacts

Public ContactPeter Culmer

Associate Professor

p.r.culmer@leeds.ac.uk441133432141

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026